Abnormal Ca2+ handling is thought to be related with triggered activity and mitochondria participate in Ca2+ homeostasis. We evaluated the contribution of ASI for mitochondrial ROS and Ca2+ Flux to cardiac function by using DOCA-salt hypertensive mice.Design and method:
We used the deoxycorticosterone acetate (DOCA)-salt mouse model. The ventricular myocytes isolated from mice was utilized for action potentials (APs) recording, potassium and L-type Ca2+ currents. While we measured mitochondrial ROS monitoring with confocal microscopy and the changes in cytoplasmic and mitochondrial Ca2+ by fluorescent imaging using Fluo-4 and Rhod-2. The heart tissue was used for the level of Na+-Ca2+ exchange (NCX) protein measurements by western blotting.Results:
The left ventricular volume was significantly enlarged, and the ejection fraction was reduced (40.8 ± 5.2% vs. 55.6 ± 74%, p < 0.05) in cardiomyopathic mice of hypertension. Myocytes showed a decreased Ca2+ transients and a significant increase in the AP duration at 90% repolarization from 83.4 ± 21.1 to 242.3 ± 43.3ms, explained by augmented L-type Ca2+ current and decreased total K+ currents. Treatment of myocytes with ASI restored AP duration at 90% repolarization cardiomyopathic mice(197.47 ± 85.85). Compared with the sham cells, the peak amplitudes (F/F0) of cytoplasmic Ca2+ transients were reduced by 33% (3.82 ± 0.35 vs. 2.56 ± 0.38, p < 0.05) in myopathic ventricular cells. After external application of ASI to cardiomyopathic cells, the peak amplitudes of cytoplasmic Ca2+ transients enhanced from 2.56 ± 0.38 to 6.10 ± 0.85 (p < 0.01). The mitochondrial ROS overproduction was observed (2.9 ± 0.3 fold of sham, P < 0.01) in myocytes of cardiomyopathic mice vs. sham. Treatment of myocytes with ASI reduced the mitochondrial ROS level of cardiomyopathic mice. The level of NCX was decreased in the cardiomyopathic mice compared with the sham mice (p = 0.016), however, ASI improved the NCX level.Conclusions:
Mitochondrial Ca2+ handling and ROS play an important role in cardiomyopathy. The scavenging mitochondrial ROS by ASI might be beneficial in the setting of hypertensive cardiomyopathy. The antioxidantive effects of ASI in heart failure may be related to regulate the mitochondrial Ca2+ Flux.